The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
MicroRNA Expression Aberration as Potential Peripheral Blood Biomarkers for Schizophrenia
Open accessAbstract
Since brain tissue is not readily accessible, a new focus in search of biomarkers for schizophrenia is blood-based expression profiling of non-protein coding genes such as microRNAs (miRNAs), which regulate gene expression by inhibiting the translation of messenger RNAs. This study aimed to identify potential miRNA signature for schizophrenia by comparing genome-wide miRNA expression profiles in patients with schizophrenia vs. healthy controls. A genome-wide miRNA expression profiling was performed using a Taqman array of 365 human miRNAs in the mononuclear leukocytes of a learning set of 30 cases and 30 controls. The discriminating performance of potential biomarkers was validated in an independent testing set of 60 cases and 30 controls. The expression levels of the miRNA signature were then evaluated for their correlation with the patients' clinical symptoms, neurocognitive performances, and neurophysiological functions. A seven-miRNA signature (hsa-miR-34a, miR-449a, miR-564, miR-432, miR-548d, miR-572 and miR-652) was derived from a supervised classification with internal cross-validation, with an area under the curve (AUC) of receiver operating characteristics of 93%. The putative signature was then validated in the testing set, with an AUC of 85%. Among these miRNAs, miR-34a was differentially expressed between cases and controls in both the learning (P = 0.005) and the testing set (P = 0.002). These miRNAs were differentially correlated with patients' negative symptoms, neurocognitive performance scores, and event-related potentials. The results indicated that the mononuclear leukocyte-based miRNA profiling is a feasible way to identify biomarkers for schizophrenia, and the seven-miRNA signature warrants further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“miR-34 dysregulation is related to different psychiatric disorders, including schizophrenia236, Alzheimer’s disease,237 and MDD.238”
From Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential (2023) · cites this paper as [236]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Gene selection for cancer classification using support vector machines
Guyon, I., Weston, J., Barnhill, S., & Vapnik, V. (2002) · Machine Learning · doi:10.1023/a:1012487302797 · Cited by 9,954
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzen, E. (2008) · Wiley eBooks · doi:10.1002/9780470373699.speced0655 · Cited by 8,467
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Wisconsin Card Sorting Test Manual – Revised and Expanded
Heaton, R. K., Chelune, C., Talley, J., Kay, G., & Curtiss, G. (1981) · Medical Entomology and Zoology · Cited by 2,975
The microRNA.org resource: targets and expression
Betel, D., Wilson, M. T., Gabow, A. P., Marks, D. S., & Sander, C. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm995 · Cited by 2,530
Flagged first, then by citations
Research works printed but not linked: 1
- JJ Cheng, 1996, Positive and Negative Syndrome Scale (PANSS): establishment and reliability study of a Mandarin Chinese language version., Chinese Psychiatry, 10, 251
Cited by
Sorted by citations
Items 101–200 of 229
Wu, Y., Chen, W. J., Hsieh, W., Tsao, P., Yu, S., Lai, C.-Y., Lee, W., & Jeng, S. (2013) · Respiratory Care · doi:10.4187/respcare.02166 · Cited by 36
Self-citationLinnstaedt, S. D., Walker, M. G., Parker, J. S., Yeh, E., Sons, R., Zimny, E., Lewandowski, C., Hendry, P. L., Damiron, K., Pearson, C., et al. (2015) · Molecular Pain · doi:10.1186/s12990-015-0069-3 · Cited by 35
MicroRNA-7/Shank3 axis involved in schizophrenia pathogenesis
Zhang, J., Sun, X., & Zhang, L.-Y. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.01.031 · Cited by 36
Identification of serum microRNAs as diagnostic biomarkers for schizophrenia
He, K., Guo, C., Guo, M., Tong, S., Zhang, Q., Sun, H., He, L., & Shi, Y. (2019) · Hereditas · doi:10.1186/s41065-019-0099-3 · Cited by 35
Giridharan, V. V., Thandavarayan, R. A., Fries, G. R., Walss‐Bass, C., Barichello, T., Justice, N., Reddy, M. K., & Quevedo, J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.220 · Cited by 34
Fusté, M., Pinacho, R., Meléndez-Pérez, I., Villalmanzo, N., Villalta‐Gil, V., Haro, J. M., & Ramos, B. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.07.019 · Cited by 33
Schmidt, U., Keck, M. E., & Buell, D. R. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.03.014 · Cited by 33
Coding and Noncoding Gene Expression Biomarkers in Mood Disorders and Schizophrenia
Mamdani, F., Martin, M. V., Lencz, T., Rollins, B. L., Robinson, D. G., Moon, E. A., Malhotra, A. K., & Vawter, M. P. (2013) · Disease Markers · doi:10.1155/2013/748095 · Cited by 33
Patient-Derived In Vitro Models of Microglial Function and Synaptic Engulfment in Schizophrenia
Sheridan, S. D., Horng, J. E., & Perlis, R. H. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.01.004 · Cited by 30
High-Throughput Approaches for MicroRNA Expression Analysis
Dedeoğlu, B. G. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-748-8_6 · Cited by 35
MicroRNAs in Post-traumatic Stress Disorder
Snijders, C., de Nijs, L., Baker, D. G., Hauger, R. L., van den Hove, D., Kenis, G., Nievergelt, C. M., Boks, M. P., Vermetten, E. H. G. J. M., Gage, F. H., et al. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_32 · Cited by 31
Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers
Fleischer, L. M., Somaiya, R. D., & Miller, G. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00683 · Cited by 32
Ragan, C., Patel, K., Edson, J., Zhang, Z. H., Gratten, J., & Mowry, B. J. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2016.11.024 · Cited by 27
Insights into psychosis risk from leukocyte microRNA expression
Jeffries, C. D., Perkins, D. O., Chandler, S. D., Stark, T., Yeo, E., Addington, J., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.148 · Cited by 29
Wang, P., Cao, T., Chen, J., Jiang, Y., Wang, C., Waddington, J. L., & Zhen, X. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107675 · Cited by 27
The Utility of Gene Expression in Blood Cells for Diagnosing Neuropsychiatric Disorders
Woelk, C. H., Singhania, A., Pérez‐Santiago, J., Glatt, S. J., & Tsuang, M. T. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00003-1 · Cited by 26
Rampino, A., Walker, R., Torrance, H., Anderson, S. M., Fazio, L., Giorgio, A. D., Taurisano, P., Gelao, B., Romano, R., Masellis, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099892 · Cited by 29
Mapping miRNA Research in Schizophrenia: A Scientometric Review
Lim, M., Carollo, A., Neoh, M. J. Y., & Esposito, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010436 · Cited by 26
Peripheral Signatures of Psychiatric Disorders: MicroRNAs
Camkurt, M. A., Güneş, S., Coşkun, S., & Fındıklı, E. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.4.313 · Cited by 26
Research Progress on the Correlation Between Epigenetics and Schizophrenia
Chen, Q., Li, D., Jin, W., Shi, Y., Li, Z., Ma, P., Sun, J., Chen, S., Li, P., & Lin, P. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.688727 · Cited by 26
Sabaie, H., Moghaddam, M. M., Moghaddam, M. M., Amirinejad, N., Asadi, M. R., Daneshmandpour, Y., Hussen, B. M., Taheri, M. N., & Rezazadeh, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-04326-0 · Cited by 25
miRNA Digger: a comprehensive pipeline for genome-wide novel miRNA mining
Yu, L., Shao, C., Ye, X., Meng, Y., Zhou, Y., & Chen, M. (2016) · Scientific Reports · doi:10.1038/srep18901 · Cited by 24
Lu, S., Ma, S., Wang, Y., Huang, T., Zhu, Z., & Zhao, G. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6559 · Cited by 24
The Significance of MicroRNA-449a and Its Potential Target HDAC1 in Patients With Colorectal Cancer
Ishikawa, D., Takasu, C., Kashihara, H., Nishi, M., Tokunaga, T., Higashijima, J., Yoshikawa, K., Yasutomo, K., & Shimada, M. (2019) · Anticancer Research · doi:10.21873/anticanres.13414 · Cited by 24
Antipsychotic drug-associated gene–miRNA interaction in T-lymphocytes
Gardiner, E. J., Carroll, A. P., Tooney, P. A., & Cairns, M. J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001752 · Cited by 24
An integrative functional genomics approach for discovering biomarkers in schizophrenia
Vawter, M. P., Mamdani, F., & Macciardi, F. M. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elr036 · Cited by 23
Screening of schizophrenia associated miRNAs and the regulation of miR-320a-3p on integrin β1
Wang, Y., Wang, J., Guo, T., Peng, Y., Wang, K., Bai, K., & Huang, Y. (2019) · Medicine · doi:10.1097/md.0000000000014332 · Cited by 23
Self-citationYuan, J., Cheng, Z., Zhang, F., Zhou, Z., Yu, S., & Jin, C. (2014) · Molecular Genetics and Genomics · doi:10.1007/s00438-014-0924-3 · Cited by 22
Self-citationGenetic Basis of Positive and Negative Symptom Domains in Schizophrenia
Xavier, R. M., & Vorderstrasse, A. A. (2017) · Biological Research For Nursing · doi:10.1177/1099800417715907 · Cited by 22
miRNAs as potential diagnostic biomarkers and pharmacogenomic indicators in psychiatric disorders
Tsermpini, E. E., Kalogirou, C., Kyriakopoulos, G. C., Patrinos, G. P., & Stathopoulos, C. (2022) · The Pharmacogenomics Journal · doi:10.1038/s41397-022-00283-7 · Cited by 22
de Bartolomeis, A., Iasevoli, F., Tomasetti, C., & Buonaguro, E. F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8962-8 · Cited by 21
Xu, Y., Zhang, Y., Long, Q., Liu, Z., Ma, X., Lu, Z., Yang, W., Feng, Z., Zhang, W., Teng, Z., et al. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11513 · Cited by 22
The Long-Term Effects of Early Life Stress on the Modulation of miR-19 Levels
Mazzelli, M., Maj, C., Mariani, N., Mora, C., Begni, V., Pariante, C. M., Riva, M. A., Cattaneo, A., & Cattane, N. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00389 · Cited by 21
From dysregulated microRNAs to structural alterations in the striatal region of METH-injected rats
Chavoshi, H., Boroujeni, M. E., Abdollahifar, M., Amini, A., Tehrani, A. M., Moghaddam, M. H., Norozian, M., Farahani, R. M., & Aliaghaei, A. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101854 · Cited by 21
Biochemical Correlates of Video Game Use: From Physiology to Pathology. A Narrative Review
Carpita, B., Muti, D., Nardi, B., Benedetti, F., Cappelli, A., Cremone, I. M., Carmassi, C., & Dell’Osso, L. (2021) · Life · doi:10.3390/life11080775 · Cited by 20
Ying, S., Heung, T., Zhang, Z., Yuen, R. K. C., & Bassett, A. S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.812183 · Cited by 21
Blood transcriptomic markers for major depression: from animal models to clinical settings
Redei, E. E., & Mehta, N. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12748 · Cited by 20
The Role of microRNA Expression in Cortical Development During Conversion to Psychosis
Zheutlin, A. B., Jeffries, C. D., Perkins, D. O., Chung, Y., Chekroud, A. M., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Mathalon, D. H., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.34 · Cited by 20
The Biomarker and Therapeutic Potential of Circular Rnas in Schizophrenia
Nedoluzhko, A., Gruzdeva, N. M., Сергеевич, Ш. Ф., Rastorguev, S., Zakharova, N. V., Kostyuk, G. P., & Ushakov, V. (2020) · Cells · doi:10.3390/cells9102238 · Cited by 18
Targeting of miR-432 to myozenin1 to regulate myoblast proliferation and differentiation
Ren, R. M., Liu, H., Zhao, S. H., & Cao, J. H. (2016) · Genetics and Molecular Research · doi:10.4238/gmr15049313 · Cited by 19
Hydrolysis by catalytic IgGs of microRNA specific for patients with schizophrenia
Ermakov, E. A., Ivanova, S. А., Buneva, V. N., & Nevinsky, G. A. (2018) · IUBMB Life · doi:10.1002/iub.1712 · Cited by 19
Circulating MicroRNA Expression Levels Associated With Internet Gaming Disorder
Lee, M., Cho, H., Jung, S., Yim, S., Cho, S., Chun, J., Paik, S.-H., Park, Y. E., Cheon, D. H., Lee, J. E., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00081 · Cited by 21
Napoli, E., Flores, A., Mansuri, Y., Hagerman, R. J., & Giulivi, C. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105427 · Cited by 19
MicroRNAs: A Light into the “Black Box” of Neuropediatric Diseases?
Omran, A. G., Elimam, D., Shalaby, S., Peng, J., & Yin, F. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8193-y · Cited by 18
Rao, W., Zhang, Y.-S., Ng, C. H., Cui, L.-J., Li, J., Li, L., Ungvari, G. S., Li, K.-Q., & Xiang, Y. (2021) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2021.102743 · Cited by 20
Liu, H., Xu, W., Feng, J., Ma, H., Zhang, J., Xie, X., Zhuang, D., Shen, W., Liu, H., & Zhou, W. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.679206 · Cited by 18
Blood-Based MicroRNAs in Psychotic Disorders—A Systematic Review
Grosu, Ș.-A., Dobre, M., Milanesi, E., & Hinescu, M. E. (2023) · Biomedicines · doi:10.3390/biomedicines11092536 · Cited by 19
Diagnostic and mechanistic roles of MicroRNAs in neurodevelopmental & neurodegenerative disorders
Khoodoruth, M. A. S., Khoodoruth, W. N. C., Uroos, M., Alabdulla, M., Khan, Y. S., & Mohammad, F. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106717 · Cited by 21
Fluoxetine Increases the Expression of miR-572 and miR-663a in Human Neuroblastoma Cell Lines
Mundalil Vasu, M., Anitha, A., Takahashi, T., Thanseem, I., Iwata, K., Asakawa, T., & Suzuki, K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164425 · Cited by 17
Blood-Derived RNA- and microRNA-Hydrolyzing IgG Antibodies in Schizophrenia Patients
Ermakov, E. A., Ivanova, S. А., Buneva, V. N., & Nevinsky, G. A. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918050048 · Cited by 17
Omran, A. G., Elimam, D., He, F., Peng, J., & Yin, F. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.09.020 · Cited by 17
Common microRNAs Target Established ASD Genes
Banerjee‐Basu, S., Larsen, E., & Muend, S. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00205 · Cited by 17
Chen, W. J. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32166 · Cited by 16
Self-citationMartinez, B., & Peplow, P. V. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.387966 · Cited by 16
Liao, Q., Wang, Y., Cheng, J. R., Dai, D., Zhou, X., Zhang, Y., Gao, S., & Duan, S. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2014.12.001 · Cited by 17
Expression Level of MicroRNA-449a Predicts the Prognosis of Patients With Gastric Cancer
Ishikawa, D., Yoshikawa, K., Takasu, C., Kashihara, H., Nishi, M., Tokunaga, T., Higashijima, J., & Shimada, M. (2019) · Anticancer Research · doi:10.21873/anticanres.13945 · Cited by 16
Williamson, V. S., Mamdani, M., McMichael, G. O., Kim, A. H., Lee, D., Bacanu, S., & Vladimirov, V. I. (2015) · Psychological Medicine · doi:10.1017/s0033291715000483 · Cited by 16
The SNP rs1625579 in miR-137 gene and risk of schizophrenia in Chinese population: A meta-analysis
Zhang, P., Bian, Y., Liu, N., Tang, Y., Pan, C., Hu, Y., & Tang, Z. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.02.009 · Cited by 15
Pala, E., & Denkçeken, T. (2019) · Journal of Computational Biology · doi:10.1089/cmb.2019.0412 · Cited by 14
Unravelling the genetic basis of Schizophrenia
Casey, C., Fullard, J. F., & Sleator, R. D. (2024) · Gene · doi:10.1016/j.gene.2024.148198 · Cited by 17
Horai, T., Boku, S., Okazaki, S., Otsuka, I., Ratta‐apha, W., Mouri, K., Yamaki, N., Hirata, T., & Hishimoto, A. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.09.006 · Cited by 13
Nolin, S. L., Napoli, E., Flores, A., Hagerman, R. J., & Giulivi, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115886 · Cited by 13
Wu, J., & Zhou, Z. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.01.014 · Cited by 12
Ho, C. S. H., Soh, M. W. T., & Tay, G. W. N. (2022) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2022.152363 · Cited by 12
Targets and regulation of microRNA-652-3p in homoeostasis and disease
Stevens, M. T., & Saunders, B. M. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02060-8 · Cited by 11
Liao, Q., Wang, Y., Cheng, J. R., Dai, D., Zhou, X., Zhang, Y., Li, J., Yin, H., Gao, S., & Duan, S. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4249 · Cited by 11
Systematic association analysis of microRNA machinery genes with schizophrenia informs further study
Zhang, F., Chen, Y., Liu, C., Lu, T., Yan, H., Ruan, Y., Yue, W., Wang, L., & Zhang, D. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.05.028 · Cited by 11
Self-citationIgGs-Abzymes from the Sera of Patients with Multiple Sclerosis Recognize and Hydrolyze miRNAs
Ermakov, E. A., Kabirova, E. M., Buneva, V. N., & Nevinsky, G. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062812 · Cited by 10
Peripheral Blood Non-Coding RNA as Biomarker for Schizophrenia: A Review
Xie, M., Zhang, Y., Yan, L., Jin, M., Lu, X., & Yu, Q. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2302042 · Cited by 10
Gumerov, V. M., & Hegyi, H. (2015) · Biology Direct · doi:10.1186/s13062-015-0089-y · Cited by 10
An introduction to microRNAs and their dysregulation in psychiatric disorders
Chao, Y.-L., & Chen, C. (2013) · Tzu Chi Medical Journal · doi:10.1016/j.tcmj.2012.12.003 · Cited by 11
Self-citationCho, Y., Kim, J., Vorn, R., Cho, H., Baek, W., Park, H., Yun, S., Kim, H., Cashion, A. K., Gill, J., et al. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae162 · Cited by 9
The Role of microRNA in Schizophrenia: A Scoping Review
Li, K., Zhu, L., Lv, H., Bai, Y., Chuang, G., & He, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147673 · Cited by 10
Early Detection of Lung Cancer
Hassanein, M., Aldrich, M. C., Deppen, S. A., Krueger, K. E., Grogan, E. L., & Massion, P. P. (2017) · doi:10.1002/9781118468869.ch14 · Cited by 9
Chan, Y. L., Ho, C. S. H., Tay, G. W. N., Tan, T. W., & Tang, T. B. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.066 · Cited by 10
Down Regulation of MIR-320 Gene Family Members in the Peripheral Blood of Schizophrenia Patients
Vachev, T. I., Popov, N. T., Stoyanova, V. K., Ivanov, H. Y., & Minchev, D. S. (2016) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2016.501.020 · Cited by 8
Leem, K. H., Kim, S.-A., Kim, H. W., & Park, H. J. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14121 · Cited by 7
Evaluation of miRNA as Biomarkers of Emotional Valence in Pigs
Marsh, L., Hutchinson, M. R., McLaughlan, C. J., Musolino, S. T., Hebart, M. L., Terry, R., Verma, P. J., Hiendleder, S., & Whittaker, A. L. (2021) · Animals · doi:10.3390/ani11072054 · Cited by 8
MicroRNAs as biomarkers and molecular mediators of cognitive dysfunction in schizophrenia
Adly, N. M., Khalifa, D., Abdel-Ghany, S. E., & Sabit, H. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02993-1 · Cited by 6
Zaki, M. B., Abulsoud, A. I., Ashraf, A., Abdelmaksoud, N. M., Sallam, A.-A. M., Aly, S. H., El-Tokhy, F. S., Rashad, A. A., El‐Dakroury, W. A., Mageed, S. S. A., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155102 · Cited by 6
Miyano, T., Hirouchi, M., Yoshimura, N., Hattori, K., Mikkaichi, T., & Kiyosawa, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413522 · Cited by 6
Yoshikawa, A., Nishimura, F., Inai, A., Eriguchi, Y., Nishioka, M., Takaya, A., Tochigi, M., Kawamura, Y., Umekage, T., Kato, K., et al. (2018) · Human Genome Variation · doi:10.1038/hgv.2017.56 · Cited by 6
Tonk, O., Tokgün, P. E., Yılmaz, Ö. S., Tokgün, O., Inci, K., Çelikkaya, B., & Altıntaş, N. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04070-2 · Cited by 5
Alteration of microRNA expression in lymphocytes in patients with first-episode schizophrenia
Huang, J., & Wang, X. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06659-w · Cited by 5
Biomarkers for drugs of abuse and neuropsychiatric disorders
Multani, P. K., Saini, N., Kaur, R., & Sharma, P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404630-6.00059-2 · Cited by 5
Vachev, T. I., Popov, N. T., Marchev, D., Ivanov, H. Y., & Stoyanova, V. K. (2016) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2016.507.055 · Cited by 5
Kotas, M., Stańczykiewicz, B., Sporniak, B., Pawlak, E., & Misiak, B. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106292 · Cited by 4
Khavari, B., Barnett, M. M., Mahmoudi, E., Geaghan, M. P., Graham, A., & Cairns, M. J. (2024) · Life · doi:10.3390/life14050562 · Cited by 5
Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs
Milanesi, E., Maj, C., Bocchio‐Chiavetto, L., & Maffioletti, E. (2016) · Drug Development Research · doi:10.1002/ddr.21344 · Cited by 4
Zhang, D., Li, H., Ding, K., Zhang, Z., Luo, S., & Li, G. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/1959172 · Cited by 4
RetractedŚmierciak, N., Krzyściak, W., Szwajca, M., Kazek, G., Urbanek, K., Bryll, A., & Pilecki, M. W. (2018) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2018.0046 · Cited by 3
Rodrigues, A. M., Anna, C. D. C. S., Alcântara, D. D. F. Á., Cohen-Paes, A. D. N., Imbiriba, M. M. B. G., & Burbano, R. M. R. (2024) · Psychiatry International · doi:10.3390/psychiatryint5040070 · Cited by 3
Epigenetic Control in Schizophrenia
D’Addario, C., & Bartolomeo, M. D. (2025) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-75980-2_5 · Cited by 3
Buneva, V. N., Ermakov, E. A., & Nevinsky, G. A. (2018) · InTech eBooks · doi:10.5772/intechopen.73194 · Cited by 3
Epigenetic biomarkers in neuropsychiatric disorders
Lin, C.-C., & Huang, T. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800226-1.00003-4 · Cited by 4
The Role of MicroRNAs in Stress-Induced Psychopathologies
Issler, O., & Chen, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00011-5 · Cited by 2
Khosroshahi, P. A., & Ghanbari, M. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111081 · Cited by 4
Mild anxiety and depression related to elevated dopamine level
Fidianingsih, I., Nurmasitoh, T., Arjana, A. Z., Devita, N., & Khoiriyah, U. (2019) · Universa Medicina · doi:10.18051/univmed.2019.v38.48-55 · Cited by 2
Non-Coding RNAs and Psychiatric Disorders
Peedicayil, J., & Beveridge, N. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417114-5.00012-7 · Cited by 2
Balmayor, E. R., Tellado, S. F., & van Griensven, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.09320-6 · Cited by 2
Metadata
- Authors
- Lai, C.-Y., Yu, S.-L., Hsieh, M. H., Chen, C.-H., Chen, H.-Y., Wen, C.-C., Huang, Y.-H., Hsiao, P.-C., Hsiao, C. K., Liu, C.-M., Yang, P.-C., Hwu, H.-G., & Chen, W. J.
- Affiliations
- National Taiwan University (TW)
- Institute of Statistical Science, Academia Sinica (TW)
- Corresponding author
- Chen, Wei J.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-06-29
- Volume
- 6
- Issue
- 6
- Pages
- e21635
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3126851
- OpenAlex
- W2065980876
- Cited by
- 228
- References
- 75
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 13 · 2023: 6 · 2022: 8 · 2021: 18 · 2020: 10 · 2019: 13 · 2018: 18 · 2017: 20 · 2016: 25 · 2015: 18 · 2014: 29 · 2013: 20 · 2012: 12
- FWCI
- 14.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Science Council (NSC98-2314-B-002-125-MY3)
- National Health Research Institutes (NHRI-EX99-9511PP)
- National Taiwan University (97R0337, 97HP0071, 97HP0023)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- schizophrenia, microRNA expression, peripheral blood biomarkers, microRNA signature, mononuclear leukocytes, miR-34a, negative symptoms, neuropsychological performance, event-related potentials, blood-based diagnosis
- MeSH terms
- Humans, Schizophrenia, Biomarkers, Case-Control Studies, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review